Navigation Links
BioBDx to Present at the 2011 BioPharm America Conference
Date:8/31/2011

PLYMOUTH MEETING, Pa., Aug. 31, 2011 /PRNewswire/ -- BioBDx announced today that the Company's Chairman and CEO Byron Hewett will present at the 2011 BioPharm America Conference taking place September 7-9.  BioBDx manufactures and markets the Quotient® System, a tool that objectively measures brain functions related to deficits in response inhibition. The first FDA-cleared application of this platform technology is objective measurement of hyperactivity, impulsivity and inattention as an aid in the assessment of attention-deficit hyperactivity disorder (ADHD).  Mr. Hewett will provide a company overview and update on the Quotient ADHD System on Thursday, September 8 at 4:15 p.m. EDT in the Otis room at the Westin Boston Waterfront Hotel in Boston, MA.

About the Quotient® ADHD TestThe Quotient® ADHD Test measures motion and analyzes shifts in attention state to give an objective picture of the core symptom areas of ADHD.  Clinicians use the Quotient® ADHD Test at the initial visit to assess severity of the three core symptoms of ADHD; hyperactivity, inattention and impulsivity.  Patients may be re-assessed periodically at follow-up visits to guide treatment plans.  The clinician integrates the Quotient® ADHD Test report with information from other assessment tools and the clinical evaluation to help guide the discussion on the treatment plan. For more information about the Quotient® ADHD System, please visit http://www.biobdx.com/products

About BioBehavioral Diagnostics CompanyBioBDx manufactures and markets the Quotient System, a tool that aids in the objective and accurate assessment of neural control functions related to deficits in inhibitory control.  We are dedicated to providing physicians, parents and patients with high-value information to guide personalized strategies and to enhance quality of life for patients with ADHD. &
'/>"/>

SOURCE BioBDx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- , A series of Health ... change the way retail pharmaceutical companies are perceived   ... and view pharmacies, Health First Pharmacy is redefining the ... very trendy public demands of customisation and accessibility, the ... various activities for both children and adults starting from ...
(Date:9/30/2014)... -- RFID Journal announced today that registration is now open for ... industry event focused on the use of radio frequency ... and exhibition will be held on Nov. 20, 2014, ... Chicago, Ill. RFID in Health ... use RFID to improve asset-utilization rates, reduce expenses and ...
(Date:9/30/2014)... , Sept. 30, 2014 ... CHDX ) today announced the completion of its ... $24.00 per share in cash.  Healthy Harmony is an ... ("Fosun") and Ms. Roberta Lipson , the CEO ... agreement was adopted by Chindex,s stockholders at a special ...
Breaking Medicine Technology:Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3Hear New Case Studies from Industry Leaders at RFID in Health Care 2014 2Hear New Case Studies from Industry Leaders at RFID in Health Care 2014 3Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 2Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 3Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 4Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 5
(Date:9/30/2014)... TUESDAY, Sept. 30, 2014 (HealthDay News) -- In books and ... abound. Now, new research suggests that the ... study, psychologists looked at data on more than 12,000 people ... Abo Akademi in Turku, Finland, found that women typically preferred ... this remained consistent throughout their lives. On the other ...
(Date:9/30/2014)... Jersey (PRWEB) September 30, 2014 Visiting ... visiting nurse association—is pleased to announce that Steven Landers, ... with a NJBIZ “40 Under 40” award on ... Jersey’s most accomplished young businessmen and women who have ... a commitment to business growth, professional excellence and to ...
(Date:9/30/2014)... 30, 2014 AxoGen, Inc. (NASDAQ: ... the peripheral nerve repair market, announced the presentation of ... American Society for Surgery of the Hand (ASSH) 2014 ... , The ASSH Best Paper Award ... Processed Nerve Allografts for Large Gap Nerve Discontinuities: Outcomes ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 AutoTex ... sporting the iconic pink ribbon in support of breast ... popular month for businesses and non-profits to “go pink” ... cause. , AutoTex PINK is a woman-owned company that ... They are committed to partnering with their customers ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 ... ADVISORY** , From:        Hope For ... 910.554.1505, abarnwell(at)hopeforthewarriors(dot)org , ... Celebration , Date:        Thursday, October ... Army and Navy Club, ...
Breaking Medicine News(10 mins):Health News:When It Comes to Sex Partners, Men Prefer Younger Women: Study 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 4Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 5Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 2Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 3Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2
... May 18 (HealthDay News) -- Inflammation caused by chronic heartburn ... finds. The condition -- formally known as gastroesophageal reflux ... of the esophagus doesn,t close properly, allowing stomach contents to ... can lead to changes in the tissue lining the esophagus, ...
... Steven Reinberg HealthDay Reporter , THURSDAY, May ... Administration on Thursday approved generic versions of the blood ... affordable for those patients who need it. ... effective and affordable treatment options is important. The generic ...
... and precisely deflected, shaped and focused. If we pulse ... the laser tool works even more precisely. A benefit: ... High-power, ultra-short pulses, then, are the ideal solution for ... cerebral membrane is not damaged. Or for removing tumor ...
... Endocrine Society,s new scientific statement published online today ... basic and clinical evidence related to the non-skeletal ... research regarding the associations of vitamin D with ... health. Vitamin D is a steroid hormone ...
... be detected at birth, according to new research at ... babies with a better innate response to viruses have ... "Viral respiratory infections are common during childhood," says ... "Usually they are mild, but there,s a wide range ...
... Parents of young children with epilepsy often sleep in the ... monitor their condition, but the bed-sharing may be interfering with ... finds. In the study, published in the journal ... Boston examined the sleeping arrangements of 105 families who had ...
Cached Medicine News:Health News:Chronic Heartburn May Boost Risk for Esophageal Cancer 2Health News:FDA Approves Generic Versions of Plavix 2Health News:FDA Approves Generic Versions of Plavix 3Health News:Ultra-short laser pulses for science and industry 2Health News:Experts call for clinical trials to test non-skeletal benefits of vitamin D 2Health News:Babies' susceptibility to colds linked to immune response at birth 2Health News:Babies' susceptibility to colds linked to immune response at birth 3Health News:Parents Often Lose Sleep Over Child's Epilepsy, Study Finds 2
... in the field of hammertoe implants with the ... grade silicone, these durable and lasting implants will ... flexibility while maintaining correct toe length and shape. ... Lengths are determined by the surgeon for each ...
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... has been approved for use as an ... seizures in adults and adolescents over 12 ... that are refractory to antiepileptic medications. This ... controlled, clinical trials. Efficacy, measured as median ...
Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts....
Medicine Products: